<?xml version="1.0" encoding="UTF-8"?>
<p>As mentioned in Section ‘Human Microenvironment and Lymphocyte Education’, engraftment protocols can also include the engraftment of additional human tissues or matrices, which includes: fetal or neonatal thymus, fetal liver or bone-marrow-derived mesenchymal stromal cells (among other cells/tissues). Thymus or liver tissues are commonly engrafted under the kidney capsule, prior to the injection of autologous HSC (through the intravenous route) [
 <xref rid="B279-vaccines-08-00036" ref-type="bibr">279</xref>,
 <xref rid="B280-vaccines-08-00036" ref-type="bibr">280</xref>,
 <xref rid="B281-vaccines-08-00036" ref-type="bibr">281</xref>,
 <xref rid="B282-vaccines-08-00036" ref-type="bibr">282</xref>,
 <xref rid="B283-vaccines-08-00036" ref-type="bibr">283</xref>,
 <xref rid="B284-vaccines-08-00036" ref-type="bibr">284</xref>,
 <xref rid="B285-vaccines-08-00036" ref-type="bibr">285</xref>,
 <xref rid="B286-vaccines-08-00036" ref-type="bibr">286</xref>,
 <xref rid="B287-vaccines-08-00036" ref-type="bibr">287</xref>] or not [
 <xref rid="B275-vaccines-08-00036" ref-type="bibr">275</xref>]. For the development of humanized ossicles, bone-marrow-derived mesenchymal stromal cells can be engrafted subcutaneously by either direct injection [
 <xref rid="B299-vaccines-08-00036" ref-type="bibr">299</xref>] or surgical implantation [
 <xref rid="B298-vaccines-08-00036" ref-type="bibr">298</xref>]. Autologous HSC can be then subsequently injected through an intravenous [
 <xref rid="B296-vaccines-08-00036" ref-type="bibr">296</xref>] or intraossicle route [
 <xref rid="B299-vaccines-08-00036" ref-type="bibr">299</xref>].
</p>
